DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 94 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q3 2022. The put-call ratio across all filers is 0.34 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $787,157 | +5.4% | 64,153 | +2.5% | 0.01% | +16.7% |
| Q2 2023 | $746,978 | +15.2% | 62,561 | +29.0% | 0.01% | 0.0% |
| Q1 2023 | $648,218 | -39.6% | 48,483 | -2.8% | 0.01% | -40.0% |
| Q4 2022 | $1,072,901 | +33.4% | 49,856 | +24.2% | 0.01% | +25.0% |
| Q3 2022 | $804,000 | +22.4% | 40,144 | +9.3% | 0.01% | +33.3% |
| Q2 2022 | $657,000 | +4.0% | 36,730 | -42.3% | 0.01% | -14.3% |
| Q1 2022 | $632,000 | -47.7% | 63,671 | -11.2% | 0.01% | -50.0% |
| Q4 2021 | $1,208,000 | – | 71,668 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 9,663,645 | $95,863,000 | 39.92% |
| Atlas Venture Life Science Advisors, LLC | 8,201,638 | $81,360,000 | 10.29% |
| RA Capital Management | 6,060,090 | $60,116,000 | 1.31% |
| Boxer Capital, LLC | 1,189,943 | $11,804,000 | 0.61% |
| Samsara BioCapital, LLC | 202,500 | $2,009,000 | 0.51% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,086,449 | $20,698,000 | 0.46% |
| BVF INC/IL | 809,282 | $8,028,000 | 0.32% |
| Summit Rock Advisors, LP | 33,125 | $329,000 | 0.20% |
| Perceptive Advisors | 556,047 | $5,516,000 | 0.11% |
| Nan Fung Group Holdings Ltd | 11,445 | $114,000 | 0.05% |